3-11-21 - Impact of SARS-CoV-2 spike protein variation on therapeutics and vaccines

Targeting Spike protein for effective vaccine and therapeutics against SARS-CoV-2Подробнее

Effect of different SARS CoV 2 variants on COVID 19 Assays and Vaccines (Webinar Recording)Подробнее

Spike Protein: Comparing COVID vaccines to SARS CoV 2 infectionПодробнее

NETEC: SARS-CoV-2: Mutations and Variants and Strains (oh my!)Подробнее

Dynamic model of SARS-CoV-2 spike protein reveals potential new vaccine targetsПодробнее

Oncotarget | Negative Effects of the Spike Protein in SARS-CoV-2 and Some VaccinesПодробнее

Webinar (Update): Effect of different SARS CoV 2 variants on COVID 19 Assays and VaccinesПодробнее

Structural characterization of conserved neutralizing epitopes on the SARS-CoV-2 spike glycoproteinПодробнее

Powerful new antibody that neutralizes all known SARS CoV 2 variantsПодробнее

SARS-CoV-2 Vaccines and VariantsПодробнее

Genomic Analysis of SARS-COV-2: New Variants and the Vaccine (Webinar)Подробнее

SARS-CoV-2 coronavirus spike protein under siegeПодробнее

Immune repsonses to SARS CoV2 11-2021Подробнее

Effect of Different SARS-CoV-2 Variants on COVID-19 Assays and Vaccines, by Stefan Pellenz, Ph.D.Подробнее

Daniel Wrapp - Structural insights into SARS-CoV-2 S and implications for therapeutic developmentПодробнее

SARS-CoV-2 Variants | DoM Grand Rounds | 11 Aug 2021Подробнее

COVID19 & SARS-CoV-2 - The Grim Science Of Spike ProteinsПодробнее

Dr. Angela Rasmussen: Demystifying COVID-19. SARS-CoV2 Therapeutics and VaccinesПодробнее

Understanding 'Spikeopathy': A Deep Dive into the Pathogenic Nature of the COVID-19 Spike ProteinПодробнее